Biological activity-based modeling identifies antiviral leads against SARS-CoV-2
Ruili Huang, Miao Xu, Hu Zhu, Catherine Z. Chen, Wei Zhu, Emily M. Lee, Shihua He, Li Zhang, Jinghua Zhao, Khalida Shamim, Danielle Bougie, Wenwei Huang, Menghang Xia, Mathew D. Hall, Donald C. Lo, Anton Simeonov, Christopher P. Austin, Xiangguo Qiu, Hengli Tang, Wei Zheng
Topics & Concepts
Drug discoveryComputational biologyBiological activityDrugHigh-throughput screeningSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antiviral drugBiologyChemistryCoronavirus disease 2019 (COVID-19)PharmacologyIn vitroBioinformaticsBiochemistryMedicineInfectious disease (medical specialty)DiseasePathologyMosquito-borne diseases and controlComputational Drug Discovery MethodsSARS-CoV-2 and COVID-19 Research